Autolus Therapeutics plc Operating Expenses 2011-2026 | AUTL

Annual Operating Expenses Autolus Therapeutics plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	145 M	58.9 M	25.1 M	15.6 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
145 M	15.6 M	61.1 M

Quarterly Operating Expenses Autolus Therapeutics plc

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35.6 M	37.2 M	-	25 M	17.1 M	16.5 M	-	8.42 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
37.2 M	8.42 M	23.3 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.79 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Coherus BioSciences CHRS	231 M	$ 1.63	-	$ 191 M	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	158 M	$ 7.83	-	$ 214 M	Israel
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	70.6 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
AbCellera Biologics ABCL	292 M	$ 4.4	-	$ 1.31 B	Canada
Amphastar Pharmaceuticals AMPH	216 M	$ 17.3	-	$ 809 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
BioNTech SE BNTX	512 M	$ 91.99	-	$ 22.2 B	Germany
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Compugen Ltd. CGEN	40.4 M	$ 3.03	-	$ 283 M	Israel
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	10.4 M	$ 3.49	-	$ 5.75 M	Israel
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	19.3 M	$ 0.73	-	$ 33.4 M	Israel
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	305 M	$ 21.57	-	$ 2.74 B	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Fennec Pharmaceuticals FENC	50.9 M	$ 9.24	-	$ 264 M	USA
Esperion Therapeutics ESPR	343 M	$ 3.12	-	$ 649 M	USA
Eton Pharmaceuticals ETON	43.6 M	$ 29.96	-	$ 806 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Exelixis EXEL	598 M	$ 51.1	-	$ 13.9 B	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA